2Sigtermans M, Dahan A, Mooren R, et al. S(+ )-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volumeers[J ]. Anesthesiology, 2009,111 (4):892-903.
3Ikonomidou C,Bosch F, Miksa M, et al. Blockade of NM DA receptors and apoptotic neurodegeneration in the de veloping brain[J]. Science, 1999,283 : 70-74.
4Wang C, Sadovova N, Hotchkiss C, et al. Blockade of N- methyl-Daspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture [J]. Toxicol Sci,2006,91 :192-201.
5Clancy B, Finlay BL, Darlington RB, et al. Extrapolating brain development from experimental species to humans [J]. Neurotoxieology, 2007,5 : 931-937.
6Stratmann G, Sall JW, May LD, et al. lsoflurane differen tially affects neurogenesis and long term neurocognitive function in 60-day-old and 7 day-old rais[J]. Anesthesiol- ogy, 2009,110 (4) : 834-848.
7Wang C,Sadovova N,Fu X,et al. The role of NMDA re ceptors in ketamine-induced apoptosis in rat forebrain cul ture[J]. Neuroscience, 2005,132 : 967-977.
8Zou X, Patterson TA, Divine RL, et al. Prolonged expo- sure to ketamine increases neurodegeneration in the de- veloping monkey brain[J]. Int J Dev Neurosci, 2009,27 (7):727-731.
9Zhang X, Xue Z, Sun A. Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the develo- ping C57BL/6 mouse brain[J]. Neurosci Lett, 2008,447 (2/3):109-114.
10Satomoto M, Satoh Y, Terui K, et al. Neonatal exposure to sevoflurane induces abnormal social behaviors and defi- cits in fear conditioning in mice [J]. Anesthesiology, 2009,110(3) :628-637.
